Prot #ATI001-204: A Phase II Study of Ad-RTS-hIL-12 + Veledimex in Combination with Cemiplimab-rwlc (Libtayo®) in Subjects with Recurrent or Progressive Glioblastoma

Project: Research project

Status	Finished
Effective start/end date	6/5/19 → 6/5/22

Project Details